Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Pitt

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Research|July 31, 2016
Fine-Tuning Cancer Immunotherapy: Optimizing the Gut MicrobiomeJonathan M Pitt, Marie Vétizou, Nadine Waldschmitt, et al.
The Journal of Clinical Investigation|April 2, 2016
Dendritic cell-derived exosomes for cancer therapyJonathan M Pitt, Fabrice André, Sebastian Amigorena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2012
Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infectionJonathan M Pitt, Evangelos Stavropoulos, Paul S Redford, et al.
Oncoimmunology|September 19, 2017
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanomaNicolas Jacquelot, Jonathan M Pitt, David P Enot, et al.
Immunity|June 23, 2016
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic FactorsJonathan M Pitt, Marie Vétizou, Romain Daillère, et al.
Plos One|February 27, 2016
Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon SignalingJonathan M Pitt, Simon Blankley, Krzysztof Potempa, et al.
Cancer Research|May 25, 2017
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic VirotherapyLaetitia Fend, Takahiro Yamazaki, Christelle Remy, et al.
Immunological Reviews|October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillanceNorma Bloy, Pauline Garcia, Céline M Laumont, et al.
Oncoimmunology|May 4, 2016
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLCBenjamin Besse, Mélinda Charrier, Valérie Lapierre, et al.
The Journal of Clinical Investigation|February 9, 2016
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanomaNicolas Jacquelot, David P Enot, Caroline Flament, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Research|July 31, 2016
Fine-Tuning Cancer Immunotherapy: Optimizing the Gut MicrobiomeJonathan M Pitt, Marie Vétizou, Nadine Waldschmitt, et al.
The Journal of Clinical Investigation|April 2, 2016
Dendritic cell-derived exosomes for cancer therapyJonathan M Pitt, Fabrice André, Sebastian Amigorena, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2012
Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infectionJonathan M Pitt, Evangelos Stavropoulos, Paul S Redford, et al.
Oncoimmunology|September 19, 2017
Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanomaNicolas Jacquelot, Jonathan M Pitt, David P Enot, et al.
Immunity|June 23, 2016
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic FactorsJonathan M Pitt, Marie Vétizou, Romain Daillère, et al.
Plos One|February 27, 2016
Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon SignalingJonathan M Pitt, Simon Blankley, Krzysztof Potempa, et al.
Cancer Research|May 25, 2017
Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic VirotherapyLaetitia Fend, Takahiro Yamazaki, Christelle Remy, et al.
Immunological Reviews|October 14, 2017
Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillanceNorma Bloy, Pauline Garcia, Céline M Laumont, et al.
Oncoimmunology|May 4, 2016
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLCBenjamin Besse, Mélinda Charrier, Valérie Lapierre, et al.
The Journal of Clinical Investigation|February 9, 2016
Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanomaNicolas Jacquelot, David P Enot, Caroline Flament, et al.
Pageof 3